| 1 | 1350088-07-1 | Losartan Impurity 10 | Losartan Impurity 10 | C22H21ClN6O2
| | |
| 2 | 23258-43-7 | 1-[2-[[4-[(2-氰基-4-硝基苯基)偶氮]苯基]乙氨基]乙基]吡啶氯化盐 | 1-[2-[[4-[(2-cyano-4-nitrophenyl)azo]phenyl]ethylamino]ethyl]pyridinium chloride | C22H21ClN6O2
| | |
| 3 | 5580-74-5 | | 1,4-Benzenedicarboxamide,N1,N4-bis[3-(aminoiminomethyl)phenyl]-, hydrochloride (1:2) | C22H21ClN6O2
| | |
| 4 | | N-[2-(5-CHLORO-1H-INDOL-3-YL)ETHYL]-N'-(4,6-DIMETHYL-2-PYRIMIDINYL)-N'-(2-FUROYL)GUANIDINE | N-[2-(5-CHLORO-1H-INDOL-3-YL)ETHYL]-N'-(4,6-DIMETHYL-2-PYRIMIDINYL)-N'-(2-FUROYL)GUANIDINE | C22H21ClN6O2
| | |
| 5 | 1609465-78-2 | 化合物 PF-303 | 1H-Pyrazole-4-carboxamide, 5-amino-3-[4-(4-chlorophenoxy)phenyl]-1-[(3R)-1-cyano-3-piperidinyl]- | C22H21ClN6O2
| | |
| 6 | 124750-92-1 | 氯沙坦羧酸 | 2-BUTYL-4-CHLORO-1-[(2'-(1-H-TETRAZOL-5-YL)[1,1'-BIPHENYL]-4-YL)METHYL]-1-H-IMIDAZOLE-5-CARBOXYLIC ACID | C22H21ClN6O2
| 原料;医药原料;杂质对照品;合成材料中间体 | |
| 7 | 327100-95-8 | 8-{2-[1-(4-chlorophenyl)ethylidene]hydrazino}-3-methyl-7-(2-phenylethyl)-3,7-dihydro-1H-purine-2,6-dione | 8-{2-[1-(4-chlorophenyl)ethylidene]hydrazino}-3-methyl-7-(2-phenylethyl)-3,7-dihydro-1H-purine-2,6-dione | C22H21ClN6O2
| | |
| 8 | 2901043-05-6 | Methanone, [(2S)-2-(6-chloro-7-methyl-1H-benzimidazol-2-yl)-2-methyl-1-pyrrolidinyl][5-hydroxy-2-(2H-1,2,3-triazol-2-yl)phenyl]- | Methanone, [(2S)-2-(6-chloro-7-methyl-1H-benzimidazol-2-yl)-2-methyl-1-pyrrolidinyl][5-hydroxy-2-(2H-1,2,3-triazol-2-yl)phenyl]- | C22H21ClN6O2
| | |